R1 RCM Inc. (RCM)
USD 14.31
(0.0%)
USD 14.31
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.25 Billion USD | 24.79% |
| 2022 | 1.8 Billion USD | 22.5% |
| 2021 | 1.47 Billion USD | 16.04% |
| 2020 | 1.27 Billion USD | 7.14% |
| 2019 | 1.18 Billion USD | 36.57% |
| 2018 | 868.5 Million USD | 93.09% |
| 2017 | 449.8 Million USD | -24.09% |
| 2016 | 592.55 Million USD | 405.43% |
| 2015 | 117.23 Million USD | -44.21% |
| 2014 | 210.14 Million USD | -58.37% |
| 2013 | 504.76 Million USD | 598.6% |
| 2012 | 72.25 Million USD | -91.26% |
| 2011 | 826.27 Million USD | 36.28% |
| 2010 | 606.29 Million USD | 18.84% |
| 2009 | 510.19 Million USD | 28.04% |
| 2008 | 398.46 Million USD | 65.53% |
| 2007 | 240.72 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 656.8 Million USD | 4.6% |
| 2024 Q1 | 603.9 Million USD | 5.01% |
| 2024 Q2 | 627.9 Million USD | 3.97% |
| 2023 Q4 | 575.1 Million USD | 0.4% |
| 2023 Q1 | 545.6 Million USD | 2.4% |
| 2023 Q3 | 572.8 Million USD | 2.16% |
| 2023 Q2 | 560.7 Million USD | 2.77% |
| 2023 FY | 2.25 Billion USD | 24.79% |
| 2022 Q3 | 496 Million USD | 26.56% |
| 2022 FY | 1.8 Billion USD | 22.5% |
| 2022 Q4 | 532.8 Million USD | 7.42% |
| 2022 Q1 | 385.7 Million USD | -3.31% |
| 2022 Q2 | 391.9 Million USD | 1.61% |
| 2021 Q1 | 342.6 Million USD | 4.32% |
| 2021 Q2 | 353.4 Million USD | 3.15% |
| 2021 Q3 | 379.7 Million USD | 7.44% |
| 2021 Q4 | 398.9 Million USD | 5.06% |
| 2021 FY | 1.47 Billion USD | 16.04% |
| 2020 Q3 | 307.2 Million USD | -2.38% |
| 2020 FY | 1.27 Billion USD | 7.14% |
| 2020 Q1 | 320.5 Million USD | 2.07% |
| 2020 Q2 | 314.7 Million USD | -1.81% |
| 2020 Q4 | 328.4 Million USD | 6.9% |
| 2019 FY | 1.18 Billion USD | 36.57% |
| 2019 Q1 | 275.9 Million USD | 4.94% |
| 2019 Q3 | 301.2 Million USD | 2.1% |
| 2019 Q2 | 295 Million USD | 6.92% |
| 2019 Q4 | 314 Million USD | 4.25% |
| 2018 Q3 | 250.4 Million USD | 20.44% |
| 2018 Q2 | 207.9 Million USD | 41.14% |
| 2018 FY | 868.5 Million USD | 93.09% |
| 2018 Q1 | 147.3 Million USD | 4.99% |
| 2018 Q4 | 262.9 Million USD | 4.99% |
| 2017 Q3 | 123.2 Million USD | 23.94% |
| 2017 Q1 | 86.9 Million USD | -18.14% |
| 2017 FY | 449.8 Million USD | -24.09% |
| 2017 Q4 | 140.3 Million USD | 13.88% |
| 2017 Q2 | 99.4 Million USD | 14.38% |
| 2016 Q3 | 125.53 Million USD | 1347.59% |
| 2016 Q4 | 106.15 Million USD | -15.44% |
| 2016 Q1 | 352.19 Million USD | 415.35% |
| 2016 FY | 592.55 Million USD | 405.43% |
| 2016 Q2 | 8.67 Million USD | -97.54% |
| 2015 Q1 | 10.97 Million USD | -76.88% |
| 2015 Q4 | 68.34 Million USD | 331.39% |
| 2015 Q3 | 15.84 Million USD | -28.27% |
| 2015 Q2 | 22.08 Million USD | 101.3% |
| 2015 FY | 117.23 Million USD | -44.21% |
| 2014 Q4 | 47.45 Million USD | -47.7% |
| 2014 Q3 | 90.74 Million USD | 53.87% |
| 2014 Q2 | 58.97 Million USD | 354.91% |
| 2014 Q1 | 12.96 Million USD | -84.54% |
| 2014 FY | 210.14 Million USD | -58.37% |
| 2013 Q1 | 28.15 Million USD | 104.39% |
| 2013 FY | 504.76 Million USD | 598.6% |
| 2013 Q3 | 18.34 Million USD | -95.1% |
| 2013 Q4 | 83.86 Million USD | 357.21% |
| 2013 Q2 | 374.4 Million USD | 1229.72% |
| 2012 Q2 | 236.68 Million USD | -6.72% |
| 2012 Q3 | 223.13 Million USD | -5.73% |
| 2012 Q1 | 253.74 Million USD | -2.44% |
| 2012 Q4 | -641.3 Million USD | -387.41% |
| 2012 FY | 72.25 Million USD | -91.26% |
| 2011 Q3 | 218.89 Million USD | 19.23% |
| 2011 Q4 | 260.08 Million USD | 18.82% |
| 2011 Q1 | 163.71 Million USD | -3.71% |
| 2011 FY | 826.27 Million USD | 36.28% |
| 2011 Q2 | 183.58 Million USD | 12.14% |
| 2010 FY | 606.29 Million USD | 18.84% |
| 2010 Q2 | 151.9 Million USD | 20.62% |
| 2010 Q4 | 170.02 Million USD | 7.33% |
| 2010 Q3 | 158.42 Million USD | 4.29% |
| 2010 Q1 | 125.93 Million USD | -8.43% |
| 2009 FY | 510.19 Million USD | 28.04% |
| 2009 Q2 | 125.68 Million USD | 11.75% |
| 2009 Q3 | 134.51 Million USD | 7.03% |
| 2009 Q4 | 137.53 Million USD | 2.24% |
| 2009 Q1 | 112.46 Million USD | 6.86% |
| 2008 Q3 | 105.95 Million USD | 0.0% |
| 2008 Q4 | 105.25 Million USD | -0.67% |
| 2008 FY | 398.46 Million USD | 65.53% |
| 2007 FY | 240.72 Million USD | 0.0% |
| 2000 Q4 | 532.79 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 667.52 Million USD | -237.696% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 88.471% |
| Sharecare, Inc. | 445.25 Million USD | -406.276% |
| Progyny, Inc. | 1.08 Billion USD | -107.074% |
| Aclarion, Inc. | 75.4 Thousand USD | -2989396.578% |
| CareMax, Inc. | 751.1 Million USD | -200.119% |
| Simulations Plus, Inc. | 70.01 Million USD | -3119.688% |
| CareCloud, Inc. | 117.05 Million USD | -1825.696% |
| Forian Inc. | 20.48 Million USD | -10906.121% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -3467900.0% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -3467900.0% |
| Minerva Surgical, Inc. | 50.29 Million USD | -4382.046% |
| Omnicell, Inc. | 1.14 Billion USD | -96.511% |
| Definitive Healthcare Corp. | 251.41 Million USD | -796.605% |
| Zhongchao Inc. | 19.43 Million USD | -11499.292% |
| Accolade, Inc. | 414.29 Million USD | -444.109% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | -9876.102% |
| Ontrak, Inc. | 12.74 Million USD | -17589.712% |
| SOPHiA GENETICS SA | 62.37 Million USD | -3514.18% |
| Spok Holdings, Inc. | 139.02 Million USD | -1521.435% |
| Privia Health Group, Inc. | 1.65 Billion USD | -35.981% |
| EUDA Health Holdings Limited | 3.7 Million USD | -60718.172% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | -1012.822% |
| TruBridge, Inc. | 339.43 Million USD | -564.104% |
| Nutex Health, Inc. | 247.64 Million USD | -810.25% |
| Renalytix Plc | 2.28 Million USD | -98379.685% |
| Sharecare, Inc. | 445.25 Million USD | -406.276% |
| Health Catalyst, Inc. | 295.93 Million USD | -661.714% |
| 10x Genomics, Inc. | 618.72 Million USD | -264.329% |
| GoodRx Holdings, Inc. | 750.26 Million USD | -200.454% |
| SCWorx Corp. | 3.8 Million USD | -59143.989% |
| Schrödinger, Inc. | 216.66 Million USD | -940.403% |
| HealthEquity, Inc. | 999.58 Million USD | -125.513% |
| HealthStream, Inc. | 279.06 Million USD | -707.775% |
| MSP Recovery, Inc. | 7.7 Million USD | -29156.327% |
| Augmedix, Inc. | 44.85 Million USD | -4925.527% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 74.46% |
| Ontrak, Inc. | 12.74 Million USD | -17589.712% |
| SHL Telemedicine Ltd. | 57.07 Million USD | -3849.54% |
| CareCloud, Inc. | 117.05 Million USD | -1825.696% |
| Premier, Inc. | 1.34 Billion USD | -67.429% |
| Certara, Inc. | 354.33 Million USD | -536.174% |
| GeneDx Holdings Corp. | 202.56 Million USD | -1012.822% |
| OneMedNet Corporation | 1.02 Million USD | -220542.861% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 74.46% |
| EUDA Health Holdings Limited | 3.7 Million USD | -60718.172% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 117.05 Million USD | -1825.696% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -308064.261% |
| CareMax, Inc. | 751.1 Million USD | -200.119% |
| Healthcare Triangle, Inc. | 33.2 Million USD | -6689.146% |
| National Research Corporation | 148.58 Million USD | -1417.162% |
| Aclarion, Inc. | 75.4 Thousand USD | -2989396.578% |
| OptimizeRx Corporation | 71.52 Million USD | -3051.779% |